Trillion-Dollar Trajectories: 3 Billion-Dollar Stocks With the Potential to Hit the Next Milestone
Buy these stock market superstars before they reach $1 Trillion Reaching the trillion-dollar market cap is a testament to any company’s international influence, massive customer base and brand power. Indeed, being considered a peer of global behemoths like Microsoft, Apple, Google, Meta and Nvidia…#apple #google #meta #nvidia #warrenbuffets #mclanecompany #pilotcorporations #pilottravelcenters #yoy #cymbalta (Source: Reuters: Health)
Source: Reuters: Health - April 11, 2024 Category: Consumer Health News Source Type: news
Perioperative Duloxetine in Laparoscopic CRC Surgery Perioperative Duloxetine in Laparoscopic CRC Surgery
Is perioperative duloxetine effective in reducing postoperative pain, decreasing opioid consumption, and improving recovery in patients undergoing laparoscopic colorectal surgery?BMC Anesthesiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 20, 2023 Category: Consumer Health News Tags: Anesthesiology Journal Article Source Type: news
The doctor didn't believe my symptoms. But I was right
One day, when I was 19 years old, I swung my legs out of bed and felt a twinge in my lower back. It didn't seem like that big of a deal, but within two weeks, I was having trouble walking. Later, I discovered I had a herniated disc in the L4-L5 part of my spine, located on the lower right above…#oakland #hispanic #vicodin #ct #cymbalta #annaacosta #smartcitydiaries #monicagreep (Source: Reuters: Health)
Source: Reuters: Health - May 21, 2023 Category: Consumer Health News Source Type: news
Most Antidepressants Ineffective At Treating Chronic Pain
Researchers found that the only antidepressant that might be useful in treating chronic pain is duloxetine. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 10, 2023 Category: Pharmaceuticals Authors: Anuradha Varanasi, Contributor Tags: Healthcare /healthcare Innovation /innovation standard Source Type: news
Most antidepressants prescribed for chronic pain lack reliable evidence of efficacy or safety, scientists warn
Largest ever investigation into antidepressants used for chronic pain shows insufficient evidence to determine how effective or harmful they may be.Study reviewed commonly prescribed medications including amitriptyline, duloxetine, fluoxetine, citalopram, paroxetine, and sertraline.One third of people globally are living with long-term pain with many prescribed antidepressants to relieve symptoms.Most antidepressants used for chronic pain are being prescribed with “insufficient” evidence of their effectiveness, scientists have warned.A major investigation into medications used to manage long-term pain found that harms ...
Source: Cochrane News and Events - May 9, 2023 Category: Information Technology Authors: Muriah Umoquit Source Type: news
Combination therapy for painful diabetic neuropathy is safe and effective
This study (a randomised controlled trial) compared the effectiveness of pregabalin, amitriptyline, and duloxetine. It showed that combinations of these drugs were safe, and equally effective at relieving pain.
Clinicians can be reassured that patients can be started on any one of the 3 medications and have another added, if needed. They could discuss the side effects associated with each medication and ask the patient which they would prefer. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - April 6, 2023 Category: Consumer Health News Source Type: news
Palliative Care in Assisted Living
Mrs. M is a 92-year-old woman residing in an assisted living community. Her medical history includes hypertension, gout, hyperlipidemia, atrial fibrillation, hypothyroidism, and melanoma with invasion into the parotid gland; she has had removal of a lesion and a parotidectomy with nerve involvement impacting the 7th cranial nerve. Her medications include oral levothyroxine, 100 μg daily; oral vitamin D, 1,000 units daily; oral probenecid 500/colchicine, 0.5 mg daily; oral lisinopril, 5 mg daily; oral furosemide, 20 mg daily; oral duloxetine, 60 mg for depression; oral carvedilol, 6.25 mg twice a day; oral aspirin, 81 mg d...
Source: Caring for the Ages - March 29, 2022 Category: Health Management Authors: Barbara Resnick, Paige Hector Tags: Interdisciplinary Team Case Studies Source Type: news
Cymbalta (duloxetine) vs. Effexor (XR, venlafaxine)
Title: Cymbalta (duloxetine) vs. Effexor (XR, venlafaxine)Category: MedicationsCreated: 2/22/2018 12:00:00 AMLast Editorial Review: 12/7/2021 12:00:00 AM (Source: MedicineNet Depression General)
Source: MedicineNet Depression General - December 7, 2021 Category: Psychiatry Source Type: news
Cymbalta (duloxetine) vs. Effexor XR (venlafaxine)
Title: Cymbalta (duloxetine) vs. Effexor XR (venlafaxine)Category: MedicationsCreated: 2/22/2018 12:00:00 AMLast Editorial Review: 12/7/2021 12:00:00 AM (Source: MedicineNet Depression General)
Source: MedicineNet Depression General - December 7, 2021 Category: Psychiatry Source Type: news
What Are the Most Common Side Effects of Cymbalta
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - August 31, 2021 Category: General Medicine Source Type: news
Suicidality and other severe psychiatric events with duloxetine: re-analysis of safety data from a placebo-controlled trial for juvenile fibromyalgia - Hengartner MP, Ploderl M.
BACKGROUND: In antidepressant trials for pediatric patients with depression or anxiety disorders, the risk of suicidal events and other severe psychiatric adverse events such as aggression and agitation is increased with antidepressants relative to placebo... (Source: SafetyLit)
Source: SafetyLit - August 18, 2021 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
Duloxetine versus 'active' placebo, placebo or no intervention for major depressive disorder; a protocol for a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis - Siddiqui F, Barbateskovic M, Juul S, Katakam KK, Munkholm K, Gluud C, Jakobsen JC.
BACKGROUND: Major depression significantly impairs quality of life, increases the risk of suicide, and poses tremendous economic burden on individuals and societies. Duloxetine, a serotonin norepinephrine reuptake inhibitor, is a widely prescribed antidepr... (Source: SafetyLit)
Source: SafetyLit - June 14, 2021 Category: International Medicine & Public Health Tags: Program and Other Evaluations, Effectiveness Studies Source Type: news
Duloxetine Cuts Opioid Use After Total Knee Arthroplasty
TUESDAY, May 25, 2021 -- As part of a multimodal analgesic regimen in patients undergoing total knee arthroplasty, duloxetine cuts opioid use compared with placebo, according to a study presented at the annual Regional Anesthesiology and Acute Pain... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 25, 2021 Category: Pharmaceuticals Source Type: news
HSS researchers find duloxetine may reduce opioid use after total knee replacement
(Hospital for Special Surgery) In a study conducted by researchers at HSS, cumulative opioid use was reduced by 30% in a patient group that received duloxetine after total knee arthroplasty (TKA) compared with patients who received placebo. Patients who received duloxetine also reported higher pain management satisfaction and less pain interference with mood, walking, normal sleep, and work activities. These findings were presented at the 2021 Spring American Society of Regional Anesthesia and Pain Medicine (ASRA) Annual Meeting. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 13, 2021 Category: International Medicine & Public Health Source Type: news
Author Q & A: New generation antidepressants for depression in children and adolescents
In this author interview we find out more about this recently published Network Meta-analysis,New generation antidepressants for depression in children and adolescents. Authors Dr. Sarah Hetrick and Nick Meader tell us about this work.What were you trying to find out with this Network Meta-Analysis?We were trying to find out how well newer generation antidepressants work compared with placebo and if some are more effective than others. We wanted to know how these antidepressants affect:symptoms of depression;recovery: no longer meeting diagnostic criteria for major depressive disorder;response or remission: scores on a sca...
Source: Cochrane News and Events - May 11, 2021 Category: Information Technology Authors: Rachel Klabunde Source Type: news
